VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SXTC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SXTCChina SXT Pharmaceuticals, Inc.
$2.03$819958
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSXTCQuarterly Financials

China SXT Pharmaceuticals, Inc. (SXTC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

China SXT Pharmaceuticals, Inc. (SXTC) quarterly income statement — complete revenue, gross profit & net income history

SXTC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue455.71K455.71K414.75K414.75K494.46K494.46K939.58K469.79K763.39K381.7K1.21M604.14K-11.5M787.3K1.03M513.84K-9.33M458.54K1.93M1.93M
Revenue Growth %-7.84%-7.84%-55.86%-11.72%-35.23%29.54%-22.24%-22.24%106.64%-51.52%17.57%17.57%-23.32%71.7%-46.76%-73.38%-280.68%-52.9%-39.96%20.07%
Cost of Goods Sold339.37K339.37K347.37K347.37K361.64K361.64K753.99K325.62K426.8K213.4K1.12M559.3K4.03M323.46K703.72K351.86K3.44M449.23K519.78K519.78K
COGS % of Revenue74.47%74.47%83.75%83.75%73.14%73.14%80.25%69.31%55.91%55.91%92.58%92.58%-35.02%41.08%68.48%68.48%-36.89%97.97%26.93%26.93%
Gross Profit116.34K116.34K67.38K67.38K132.81K132.81K185.59K144.17K336.59K168.29K89.68K44.84K-15.53M463.84K323.96K161.98K-12.77M9.31K1.41M1.41M
Gross Margin %25.53%25.53%16.25%16.25%26.86%26.86%19.75%30.69%44.09%44.09%7.42%7.42%135.02%58.92%31.52%31.52%136.89%2.03%73.07%73.07%
Gross Profit Growth %-12.41%-12.41%-63.7%-53.27%-60.54%-21.08%106.94%221.51%102.17%-63.72%-72.32%-72.32%-21.64%4883.82%-77.03%-88.52%-572.23%-97.85%-23.32%53.36%
Operating Expenses1.14M1.14M386.51K386.51K-3.28M-3.28M9.53M4.82M4.79M2.34M1.24M600K-8.44M1.77M3.22M1.55M-11.17M1.96M519.78K381.29K
OpEx % of Revenue249.6%249.6%93.19%93.19%-664.18%-664.18%1014.77%1026.84%627.94%613.61%102.64%99.31%73.38%224.36%312.89%300.69%119.77%426.51%26.93%19.75%
Selling, General & Admin1.14M1.14M386.51K386.51K3.5M3.5M9.53M4.82M4.79M2.22M1.24M620.07K-8.44M1.61M3.22M1.61M-11.17M1.69M519.78K828.56K
SG&A % of Revenue249.6%249.6%93.19%93.19%706.95%706.95%1014.77%1025.71%627.94%582.17%102.64%102.64%73.38%204.87%312.89%312.89%119.77%368.51%26.93%42.93%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses0000-1000K-1000K00000000000000
Operating Income-1.02M-1.02M-319.13K-319.13K3.42M3.42M-9.35M-4.67M-4.46M-2.05M-1.15M-575.22K1.28M-1.15M-2.89M-1.45M2.42M-1.68M581.9K581.9K
Operating Margin %-224.07%-224.07%-76.95%-76.95%691.04%691.04%-995.02%-995.02%-583.85%-538.08%-95.21%-95.21%-11.09%-145.95%-281.37%-281.37%-25.93%-366.48%30.15%30.15%
Operating Income Growth %-129.88%-129.88%96.59%93.17%176.66%266.37%-712.64%-712.64%-449.57%-78.74%60.21%60.21%-47.28%31.62%-596.91%-348.45%134.71%-199.98%363.6%627.2%
EBITDA-1.01M-1.01M-284.86K-284.86K3.47M3.47M-9.25M-4.62M-4.32M-1.98M-1.04M-520.24K1.41M-1.08M-2.71M-1.35M2.58M-1.6M764.83K673.37K
EBITDA Margin %-222.56%-222.56%-68.68%-68.68%701.2%701.2%-984.08%-984.08%-565.49%-519.72%-86.11%-86.11%-12.25%-137.44%-263.27%-263.27%-27.67%-348.76%39.62%34.88%
EBITDA Growth %-129.25%-129.25%96.92%93.84%180.32%274.78%-788.65%-788.65%-406.37%-83.33%61.54%61.54%-45.41%32.34%-453.74%-300.9%138.13%-246.87%977%1644.17%
D&A (Non-Cash Add-back)6.88K6.88K34.27K34.27K50.25K50.25K102.75K51.38K140.2K70.1K109.97K54.98K134.01K67K186K93K162.49K81.24K182.93K91.46K
EBIT-1.02M-1.02M-319.13K-319.13K3.63M3.63M-4.67M-4.67M-2.05M-2.05M-575.22K-575.22K-1.15M-1.15M-1.45M-1.45M-1.68M-1.68M581.9K581.9K
Net Interest Income-232.88K-232.88K-91.24K-91.24K000168.26K-46.24K46.24K-192.14K192.14K-3.56M18.38K3435-1.98M332.18K0221.04K
Interest Income0000000168.26K46.24K46.24K192.14K192.14K018.38K34350332.18K0221.04K
Interest Expense232.88K232.88K91.24K91.24K000092.49K0384.29K03.56M0001.98M000
Other Income/Expense-229.44K-229.44K-82.15K-82.15K-118.09K-118.09K4.5M-173.57K2.24M-166.24K403.15K-172.08K-2.6M-171.88K1.51M62.74K-4.7M-598.13K226.23K226.23K
Pretax Income-1.25M-1.25M-401.28K-401.28K3.3M3.3M-4.85M-4.85M-4.44M-2.22M-747.3K-747.3K2.38M-1.32M-2.77M-1.38M4.85M-2.28M808.14K808.14K
Pretax Margin %-274.42%-274.42%-96.75%-96.75%667.16%667.16%-515.98%-1031.96%-581.64%-581.64%-61.85%-123.7%-20.71%-167.78%-269.16%-269.16%-51.99%-496.92%41.87%41.87%
Income Tax000000003040-596.16K1.18K325.78K162.89K-75.33K-213.85K117.51K117.51K
Effective Tax Rate %0%0%0%0%0%0%0%0%-0%0%-0%0%-25.03%-0.09%-11.78%-11.78%-1.55%9.39%14.54%14.54%
Net Income-1.25M-1.25M-401.28K-401.28K3.3M3.3M-9.7M-4.85M-4.44M-2.22M-1.49M-747.3K2.32M-1.32M-3.09M-1.55M5.31M-2.06M690.63K690.63K
Net Margin %-274.42%-274.42%-96.75%-96.75%667.16%667.16%-1031.96%-1031.96%-581.64%-581.64%-123.7%-123.7%-20.19%-167.93%-300.86%-300.86%-56.93%-450.29%35.78%35.78%
Net Income Growth %-137.91%-137.91%95.86%91.72%174.29%248.59%-548.74%-548.74%-291.23%-67.92%51.66%51.66%-56.27%35.97%-547.68%-323.84%151.61%47.99%129.41%158.83%
Net Income (Continuing)-1.25M-1.25M-401.28K-401.28K3.3M3.3M-4.85M-4.85M-2.22M-2.22M-747.3K-747.3K-1.32M-1.32M-1.55M-1.55M-2.06M-2.06M690.63K690.63K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.51-0.51-0.99-0.992.673.80-9.67-9.67-5.14-5.14-7.30-7.30-25.39-25.39-49.71-49.71-71.73-71.7324.0024.00
EPS Growth %-119.1%-113.42%89.76%89.76%151.95%173.93%-32.47%-32.47%79.76%79.76%85.31%85.31%64.6%64.6%-307.13%-307.13%75.85%75.85%123.23%123.23%
EPS (Basic)-0.51-0.51-0.99-0.992.672.67-9.67-9.67-5.14-5.14-7.30-7.30-25.39-25.39-49.71-49.71-71.73-71.7324.0024.00
Diluted Shares Outstanding2.44M2.44M403.92K403.92K1.23M867.42K501.47K501.47K431.63K431.63K102.32K102.32K52.08K52.08K31.1K31.1K28.78K28.78K28.78K28.78K
Basic Shares Outstanding2.44M2.44M403.92K403.92K1.23M867.42K501.47K501.47K431.63K431.63K102.32K102.32K52.08K52.08K31.1K31.1K28.78K28.78K28.78K28.78K
Dividend Payout Ratio--------------------